Description
Overview
This cutting-edge blend combines Retatrutide (a GIP/GLP-1/glucagon triple agonist) with Cagrilintide (a long-acting amylin analog). This multi-receptor approach targets four distinct metabolic pathways simultaneously.
Specifications
- Retatrutide: 5mg | Cagrilintide: 5mg
- Form: Lyophilized powder
- Storage: Store at -20°C
- Documentation: COAs available upon request. Ask support to confirm the report for this item and batch.
For research use only. Not for human consumption.

Reviews
There are no reviews yet.